KLK3 and prostate cancer: For example, dendritic cells transfected with mRNA encoding prostate-specific antigen (PSA) TAAs induced potent PSA-specific T-cell responses in prostate cancer patients and elicited a substantial decline in PSA level in 6 out of 7 patients [24].